114 related articles for article (PubMed ID: 24135150)
1. Appropriate evidence sources for populating decision analytic models within health technology assessment (HTA): a systematic review of HTA manuals and health economic guidelines.
Zechmeister-Koss I; Schnell-Inderst P; Zauner G
Med Decis Making; 2014 Apr; 34(3):288-99. PubMed ID: 24135150
[TBL] [Abstract][Full Text] [Related]
2. Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review.
Chilcott J; Tappenden P; Rawdin A; Johnson M; Kaltenthaler E; Paisley S; Papaioannou D; Shippam A
Health Technol Assess; 2010 May; 14(25):iii-iv, ix-xii, 1-107. PubMed ID: 20501062
[TBL] [Abstract][Full Text] [Related]
3. USING EXPERT OPINION IN HEALTH TECHNOLOGY ASSESSMENT: A GUIDELINE REVIEW.
Hunger T; Schnell-Inderst P; Sahakyan N; Siebert U
Int J Technol Assess Health Care; 2016 Jan; 32(3):131-9. PubMed ID: 27502308
[TBL] [Abstract][Full Text] [Related]
4. Health technology assessment of medical devices: What is different? An overview of three European projects.
Schnell-Inderst P; Mayer J; Lauterberg J; Hunger T; Arvandi M; Conrads-Frank A; Nachtnebel A; Wild C; Siebert U
Z Evid Fortbild Qual Gesundhwes; 2015; 109(4-5):309-18. PubMed ID: 26354131
[TBL] [Abstract][Full Text] [Related]
5. The role of decision analytic modeling in the health economic assessment of spinal intervention.
Edwards NC; Skelly AC; Ziewacz JE; Cahill K; McGirt MJ
Spine (Phila Pa 1976); 2014 Oct; 39(22 Suppl 1):S16-42. PubMed ID: 25299257
[TBL] [Abstract][Full Text] [Related]
6. Differences among formulary submission guidelines: implications for health technology assessment.
Mauskopf J; Walter J; Birt J; Bowman L; Copley-Merriman C; Drummond M
Int J Technol Assess Health Care; 2011 Jul; 27(3):261-70. PubMed ID: 21756414
[TBL] [Abstract][Full Text] [Related]
7. Identification of Evidence for Key Parameters in Decision-Analytic Models of Cost Effectiveness: A Description of Sources and a Recommended Minimum Search Requirement.
Paisley S
Pharmacoeconomics; 2016 Jun; 34(6):597-608. PubMed ID: 26861793
[TBL] [Abstract][Full Text] [Related]
8. Critical Review of European Health-Economic Guidelines for the Health Technology Assessment of Medical Devices.
Blüher M; Saunders SJ; Mittard V; Torrejon Torres R; Davis JA; Saunders R
Front Med (Lausanne); 2019; 6():278. PubMed ID: 31850356
[No Abstract] [Full Text] [Related]
9. Use of evidence in decision models: an appraisal of health technology assessments in the UK since 1997.
Cooper N; Coyle D; Abrams K; Mugford M; Sutton A
J Health Serv Res Policy; 2005 Oct; 10(4):245-50. PubMed ID: 16259692
[TBL] [Abstract][Full Text] [Related]
10. Systematic assessment of decision-analytic models for chronic myeloid leukemia.
Rochau U; Schwarzer R; Jahn B; Sroczynski G; Kluibenschaedl M; Wolf D; Radich J; Brixner D; Gastl G; Siebert U
Appl Health Econ Health Policy; 2014 Apr; 12(2):103-15. PubMed ID: 24385259
[TBL] [Abstract][Full Text] [Related]
11. Association between pacifier use and breast-feeding, sudden infant death syndrome, infection and dental malocclusion.
Callaghan A; Kendall G; Lock C; Mahony A; Payne J; Verrier L
Int J Evid Based Healthc; 2005 Jul; 3(6):147-67. PubMed ID: 21631747
[TBL] [Abstract][Full Text] [Related]
12. Are adverse effects incorporated in economic models? An initial review of current practice.
Craig D; McDaid C; Fonseca T; Stock C; Duffy S; Woolacott N
Health Technol Assess; 2009 Dec; 13(62):1-71, 97-181, iii. PubMed ID: 20018146
[TBL] [Abstract][Full Text] [Related]
13. Risk management frameworks for human health and environmental risks.
Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
[TBL] [Abstract][Full Text] [Related]
14. Systematic Review of Model-Based Economic Evaluations of Treatments for Alzheimer's Disease.
Hernandez L; Ozen A; DosSantos R; Getsios D
Pharmacoeconomics; 2016 Jul; 34(7):681-707. PubMed ID: 26899832
[TBL] [Abstract][Full Text] [Related]
15. How is evidence on test performance synthesized for economic decision models of diagnostic tests? A systematic appraisal of Health Technology Assessments in the UK since 1997.
Novielli N; Cooper NJ; Abrams KR; Sutton AJ
Value Health; 2010 Dec; 13(8):952-7. PubMed ID: 21029247
[TBL] [Abstract][Full Text] [Related]
16. [Decision-analytical modelling of costs per QALY in the context of the German Social Law].
Rogowski WH; Landauer M; John J
Gesundheitswesen; 2009 Nov; 71(11):739-50. PubMed ID: 19551622
[TBL] [Abstract][Full Text] [Related]
17. A comprehensive review of official discount rates in guidelines of health economic evaluations over time: the trends and roots.
Khorasani E; Davari M; Kebriaeezadeh A; Fatemi F; Akbari Sari A; Varahrami V
Eur J Health Econ; 2022 Dec; 23(9):1577-1590. PubMed ID: 35235078
[TBL] [Abstract][Full Text] [Related]
18. Principles of good practice for budget impact analysis: report of the ISPOR Task Force on good research practices--budget impact analysis.
Mauskopf JA; Sullivan SD; Annemans L; Caro J; Mullins CD; Nuijten M; Orlewska E; Watkins J; Trueman P
Value Health; 2007; 10(5):336-47. PubMed ID: 17888098
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
